Skip to main content
SpringerLink
Log in

Severity of the Disease, Site of Care and Self-Management

  • Chapter
  • First Online:
Bronchiectasis

  • 1035 Accesses

Abstract

Bronchiectasis is a chronic respiratory condition that for many patients results in daily symptoms, frequent exacerbations in the form of chest infections and a detrimental impact on quality of life. The cornerstone of bronchiectasis is abnormal dilation of the bronchi and this is visible on CT scanning of the thorax; however radiological assessment of bronchiectasis is not encompassing enough to fully assess severity [1]. There are patients with small, localised areas of abnormal bronchial dilatation who exhibit chronic infection, frequent exacerbations and significant symptomatology, and there are those with widespread changes on imaging who can be relatively asymptomatic. A global evaluation of the entire patient to assess disease severity is therefore required.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  1. McShane PJ, Naureckas ET, Tino G, Strek ME. Non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med. 2013;188:647–56.

    Article  PubMed  Google Scholar 

  2. Chalmers JD, Goeminne P, Aliberti S, et al. The bronchiectasis severity index. Am J Respir Crit Care Med. 2014;189(5):576–85.

    Article  PubMed  PubMed Central  Google Scholar 

  3. King PT. The pathophysiology of bronchiectasis. Int J Chron Obstruct Pulmon Dis. 2009;4:411–9.

    Article  PubMed  PubMed Central  Google Scholar 

  4. McDonnell MJ, Aliberti S, Goeminne PC, et al. Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study. Lancet. 2016;4(12):969–79.

    PubMed  PubMed Central  Google Scholar 

  5. Martinez-Garcia MA, de Gracia J, Vendrell Relat M, et al. Multidimensional approach to non-cystic fibrosis bronchiectasis: the FACED score. Eur Respir J. 2014;43:1357–67.

    Article  PubMed  Google Scholar 

  6. Ellis HC, Cowman S, Fernandes M, et al. Predicting mortality in bronchiectasis using bronchiectasis severity index and FACED scores: a 19-year cohort study. Eur Respir J. 2016;47:482–9.

    Article  PubMed  Google Scholar 

  7. McDonnell MJ, Aliberti S, Goeminne PC, et al. Multidimensional severity assessment in bronchiectasis: an analysis of seven European cohorts. Thorax. 2016;71:1110–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Martinez-Garcia MA, Athanazio RA, Girón R, et al. Predicting high risk exacerbations in bronchiectasis: the E-faced score. Int J Chron Obstruct Pulmon Dis. 2017;12:275–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Quint JK, Millett ER, Joshi M, et al. Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2014 to 2013: a population-based cohort study. Eur Respir J. 2016;47(1):186–93.

    Article  PubMed  Google Scholar 

  10. Pasteur MC, Bilton D, Hill AT. British Thoracic Society guideline for non-CF bronchiectasis. Thorax. 2010;65(Suppl 1):i1–58.

    Article  PubMed  Google Scholar 

  11. Finch S, McDonnell MJ, Abo-Leyah H, et al. A comprehensive analysis of the impact of pseudomonas aeruginosa colonisation on prognosis in adult bronchiectasis. Ann Am Thorac Soc. 2015;12(11):1602–11.

    PubMed  Google Scholar 

  12. Davies G, Wells AU, Doffman S, et al. The effect of pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis. Eur Respir J. 2006;28:974–9. https://doi.org/10.1183/09031936.06.00074605.

    Article  CAS  PubMed  Google Scholar 

  13. Swinson DR, Symmons D, Suresh U, et al. Decreased survival in patients with coexistent rheumatoid arthritis and bronchiectasis. Br J Rheumatol. 1997;36:689–91.

    Article  CAS  PubMed  Google Scholar 

  14. De Soyza A, McDonnell MJ, Goeminne PC, et al. Bronchiectasis Rheumatoid overlap syndrome (BROS) is an independent risk factor for mortality in patients with bronchiectasis: a multicentre cohort study. Chest. 2017;151(6):1247–54.

    Google Scholar 

  15. Noone PG, Leigh MW, Sannuti A, et al. Primary ciliary dyskinesia: diagnostic and phenotypic features. Am J Respir Crit Care Med. 2004;169:459–67.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Royal Infirmary and University of Edinburgh, Edinburgh, UK

    Tom M. Quinn & Adam T. Hill

Authors
  1. Tom M. Quinn
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Adam T. Hill
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Adam T. Hill .

Editor information

Editors and Affiliations

  1. College of Medicine, University of Dundee , Dundee, United Kingdom

    James Chalmers

  2. Hospital Vall D’Hebron, Vall D’Hebron Research Institute (VHIR) Respiratory Disease Department, Barcelona, Spain

    Eva Polverino

  3. Department of Pathophysiology and Transplantation, University of Milan Internal Medicine Department, Respiratory Unit and Cystic Fibrosis Adult Center, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy

    Stefano Aliberti

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Quinn, T.M., Hill, A.T. (2018). Severity of the Disease, Site of Care and Self-Management. In: Chalmers, J., Polverino, E., Aliberti, S. (eds) Bronchiectasis. Springer, Cham. https://doi.org/10.1007/978-3-319-61452-6_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-61452-6_11

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-61451-9

  • Online ISBN: 978-3-319-61452-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation